Paediatric anaesthesia
-
Paediatric anaesthesia · Feb 2018
The pharmacokinetics of intravenous ketorolac in children aged 2 months to 16 years: A population analysis.
Intravenous ketorolac is commonly administered to children for the control of postoperative pain. An effect site EC50 for analgesia of 0.37 mg. L-1 is described in adults. ⋯ Clearance, expressed as L. h-1. kg-1 , decreased with age from infancy. A dosing regimen of 0.5 mg. kg-1 every 6 hours maintains a trough concentration larger than 0.37 mg. L-1 in children 9 months to 16 years of age. This dosing regimen is consistent with current recommendations.